Nucleate co-founders see ‘new class of activators’ in biotech

"For quite a long time, people have appreciated and understood the value and the gaps that are associated with making that transition from academia to industry. One of the key bottlenecks that we identified was a lack of resources for active academic trainees to take the first steps in their career, to start a company."